Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials
  1. Home
  2. Publications
  3. Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

Authors:
  • Emmanuel S. Antonarakis
    Emmanuel S. Antonarakis
  • SSSumit K. Subudhi
    Sumit K. Subudhi
  • CPChristopher M. Pieczonka
    Christopher M. Pieczonka
  • LKLawrence I. Karsh
    Lawrence I. Karsh
  • DQDavid I. Quinn
    David I. Quinn
  • JHJason M. Hafron
    Jason M. Hafron
  • HWHelen M. Wilfehrt
    Helen M. Wilfehrt
  • MHMatthew Harmon
    Matthew Harmon
  • NSNadeem A. Sheikh
    Nadeem A. Sheikh
  • NSNeal D. Shore
    Neal D. Shore
  • DPDaniel P. Petrylak
    Daniel P. Petrylak

Open Access
Publisher website
Google Scholar
  • 16 September 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.27030949
Abstract
Supplementary Fig 3 In vivo cellular and humoral responses through 52 weeks are illustrated here.
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • GENITOURINARY CANCERS
  • PROSTATE CANCER
  • IMMUNOTHERAPY
  • CELLULAR IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.